Dr VG Somani DCGI releases IPA guidelines on Market Complaints. Medical Dialogues Bureau2 March 2020 5:00 AM GMTThe guidelines were released at the recently concluded India Pharmaceutical Forum
Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities Medical Dialogues Bureau10 Nov 2019 4:15 AM GMTAurobindo Pharma is second city-based drug company that has initiated the voluntary recall after the FDA announced an investigation into the reported...
Dr Reddys Q2 revenue up 26.4 pc to Rs 4801 crore Medical Dialogues Bureau3 Nov 2019 4:00 AM GMTRevenue in the second quarter stood at Rs 4,800.9 crore as against Rs 3,797.8 crore in the year-ago period, an increase of 26.41 per cent, Dr Reddy's...
Dr Reddys gets CDSCO Committee recommendation for approval for additional indications of Desosumab Farhat Nasim26 Oct 2019 9:08 AM GMTRecently, the Hyderabad-based Dr Reddy's Labs presented its proposal before the CDSCO Committee for an additional indication for Denosumab 120...
Dr Reddys recalls Ranitidine products in US over cancer-causing impurity Medical Dialogues Bureau24 Oct 2019 4:00 AM GMTThis recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr...
Dr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical Alliance Farhat Nasim10 Oct 2019 11:31 AM GMTDr Reddy's Labs' Chairman, Satish Reddy played a key role in shaping policies concerning the pharmaceutical sector as well as the economy, such as...
Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over Medical Dialogues Bureau23 Sep 2019 4:30 AM GMTRanitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada Medical Dialogues Bureau13 Sep 2019 6:29 AM GMTThe company has received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at the formulations...
Dr Reddys unveils generic version of Zyban ER tablets in US Medical Dialogues Bureau5 Sep 2019 11:31 AM GMTThe company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh Medical Dialogues Bureau21 Aug 2019 4:30 AM GMTThe audit of Dr Reddy's formulations manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam by the United States Food and Drug...
Eli Lilly Vs Dr Reddys, Hospira: Court rules in favour of Lilly in Alimta alternate salt form patent lawsuit Medical Dialogues Bureau13 Aug 2019 3:45 AM GMTThe ruling came in the appeals of U.S. District Court decisions in the cases of Eli Lilly and Company v. Dr Reddy's Laboratories and Eli Lilly and...
Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu Medical Dialogues Bureau20 July 2019 6:07 AM GMTIn a BSE filing, Dr Reddy's Labs(Dr Reddys) announced "launch of Fexofenadine HCI 60 mg and Pseudoephedrine HCI 120 mg extended-release tablets, USP,...
